as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
.
.
.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
.
.
(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr.